期刊文献+

3 238株致病革兰阴性杆菌在ICU和普通病房的耐药性差异分析 被引量:8

Differences in antibiotic resistance of 3 238 pathogenic gram-negative bacilli strains isolated in intensive care unit (ICU) and common wards
原文传递
导出
摘要 目的分析7种抗生素对重症监护病房(ICU)与普通病房分离的4种致病革兰阴性杆菌的耐药率差异。方法回顾性分析北京同仁医院2016年1至12月分离的3 238株革兰阴性杆菌耐药数据,其中重症组(ICU)分离菌株占比为46.6%,普通组(普通病房)为53.4%,分别检测两组分离菌株对7种抗生素的耐药性。结果重症组铜绿假单胞菌对头孢曲松、头孢吡肟和亚胺培南耐药率分别是41.7%、41.2%和39.5%,普通组这三种抗生素的耐药率分别是20.9%、21.7%和17.1%;重症组肺炎克雷伯菌对亚胺培南耐药率为17.2 %,普通组耐药率为8.8%;重症组大肠埃希菌对头孢曲松、头孢吡肟耐药率分别是72.9%和35.8%,普通组分别是44.7%和13.3%。重症组和普通组之间比较,铜绿假单胞菌对头孢曲松、头孢吡肟、亚胺培南耐药率差异大,差异均有统计学意义(χ^2头孢曲松=56.72,P〈0.01;χ头孢吡肟2=49.12,P〈0.01;χ^2亚胺培南=69.81,P〈0.01);肺炎克雷伯菌对亚胺培南耐药率差异大,差异有统计学意义(χ^2亚胺培南=11.48,P〈0.01);大肠埃希菌对头孢曲松、头孢吡肟耐药率差异大,差异均有统计学意义(χ^2头孢曲松=40.13,P〈0.01;χ^2头孢吡肟=41.61,P〈0.01);鲍曼不动杆菌对7种抗生素耐药率均〉60%,重症组和普通组耐药率差异无统计学意义。结论与普通病房相比,ICU分离株耐药率更高,抗生素应该区别使用,定期监测耐药性,为诊断前的经验用药提供依据。 Objective To detect the antibiotic resistance of four kinds of gram-negative bacilli strains against seven antibiotics and to analyze the differences in antibiotic resistance between the strains isolated in intensive care unit (ICU) and common wards. Methods This study involved 3 238 gram-negative bacilli strains isolated in Beijing Tongren Hospital from January to December 2016. Of all strains, 46.6% were isolated in ICU (severe group) and 53.4% were isolated in common wards (general group). Resist- ance of these strains to seven kinds of antibiotics was detected and the differences between the two groups were analyzed. Results Antibiotic resistance rates of Pseudomonas aeruginosa strains to ceftriaxone, cefepime and imipenem were 41.7% , 41.2% and 39.5% in severe group and 20.9%, 21.7% and 17.1% in general group. Moreover, the differences between the two groups were all statistically significant ( χ^2efatriaxone= 56.72, P〈0.01 ;χ^2Cefepime=49.12, P〈0.01 ; χ^2Imipnem= 69.81, P〈0.01 ). Antibiotic resistance rates of Klebsiella pneumoniae strains to imipenem was 17.2% in severe group and 8.8% in general group, and the difference between the two groups was statistically significant (χ^2Imipenem= 11.48, P〈0.01 ). Resistance rates of Escherichia coli strains to ceftriaxone and cefepime were 72.9% and 35.8% in severe group and 44.7% and 13.3% in general group, and the differences between the two groups were statistically sig- nificant (χ^2Ceftriaxone =40.13, P〈0.01 ; χ^2Cefepime =41.61, P〈0.01 ). More than 60% ofAcinetobacter baumanii strains whether they were isolated in ICU or in common wards were resistant to all the seven antibiotics, and there were no significant differences between the two groups. Conclusion Gram-negative bacilli strains iso- lated in ICU have higher resistance rates than those isolated in common wards and therefore antibiotics shouht be used differently. Regular monitoring of drug resistance should be strengthened to provide references for empirical clinical medication.
作者 田晓波 潘书娟 王娜 刘宇 鲁辛辛 Tian Xiaobo Pan Shujuan Wang Na Liu Yu Lu Xinxin(Department of Clinical Laboratory, Belting Tongren Hospital, Capital Medical University, Beijing 100176, China Department of Clinical Laboratory, Dongzhimen Hospital Eastern Affiliated to Beijing University of Chinese Medicine, Beifing 101100, China)
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2017年第3期225-229,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金(81371861)
关键词 阴性杆菌 抗生素 差异分析 耐药率 Gram-negative bacilli Antibiotic Difference analysis Resistance rate
  • 相关文献

参考文献5

二级参考文献74

  • 1张幸国,杜小幸,张嵘,魏泽庆,俞云松,陈亚岗,李兰娟.发现一株产KPC-2型碳青霉烯酶肺炎克雷伯菌[J].中华检验医学杂志,2006,29(9):824-826. 被引量:60
  • 2汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 3Piekarska K, Zacharczuk K, Szych J, et al. Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland[J]. Med Dosw Mikrobiol, 2010, 62( 1 ) : 9- 20.
  • 4Turner PJ. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study ( 1997- 2002) [J]. Diagn Microbiol Infect Dis, 2005, 51 (4) : 281-289.
  • 5Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneu- moniae carbapenemase-producing bacteria[J]. Lancet Infect Dis, 2009, 9(4) : 228-236.
  • 6Mendes RE, Bell JM, Turnidge JD, et al. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conju- gative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene[J]. An- timicrob Agents Chemother, 2008, 52(2) : 798-799.
  • 7Penteado AP, Castanheira M, Pignatari AC, et al. Dissemination of bla( IMP-I ) -carrying integron In86 among Klebsiella pneumoniae isolates harboring a new trimethoprim resistance gene dfr23 [ J ]. Diagn Microbiol Infect Dis, 2009, 63( 1) : 87-91.
  • 8Yan JJ, Ko WC, Tsai SH, et al. Outbreak of infection with multi- drag-resistant Klebsiella pneumoniae carrying bla( IMP-8 ) in a uni- versity medical center in Taiwan[ J]. J Clin Microbiol, 2001, 39 (12) : 4433-4439.
  • 9Cuzon G, Ouanieh J, Gondret R, et al. Outbreak of OXA48-pos- itive carbapenem-resistant Klebsiella pneumoniae isolates in France [ J]. Antimicrob Agents Chemother, 2011, 55 (5) : 2420-2423.
  • 10Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiol- ogy of the global expansion of Klebsiella pneumoniae carbapenemas- es[J]. Lancet Infect Dis, 2013, 13(9) : 785-796.

共引文献75

同被引文献55

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部